F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 14.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $227,000 | +198.7% | 36,291 | +70.5% | 0.02% | +233.3% |
| Q1 2022 | $76,000 | -30.9% | 21,291 | -2.7% | 0.01% | -25.0% |
| Q4 2021 | $110,000 | -36.4% | 21,879 | -7.3% | 0.01% | -42.9% |
| Q3 2021 | $173,000 | -13.1% | 23,604 | +2.1% | 0.01% | -6.7% |
| Q2 2021 | $199,000 | -20.4% | 23,129 | 0.0% | 0.02% | -25.0% |
| Q1 2021 | $250,000 | +9.6% | 23,129 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $228,000 | – | 23,129 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |